Education
About Us
Working with TipRanks
Follow Us
Fresenius Se (FSNUY)
OTHER OTC:FSNUY
FSNUY Stock Chart & Stats
$14.04
$0.06(0.63%)
At close: 4:00 PM EST
$14.04
$0.06(0.63%)
Day’s Range― - ―
52-Week Range$8.60 - $14.74
Previous CloseN/A
Volume6.04K
Average Volume (3M)1.96K
Market Cap
$32.01B
Enterprise Value$139.75B
Total Cash (Recent Filing)$2.78B
Total Debt (Recent Filing)$15.91B
Price to Earnings (P/E)25.4
Beta0.17
Next Earnings
Feb 25, 2026EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend Yield1.97%
Share Statistics
EPS (TTM)0.18
Shares Outstanding2,252,949,200
10 Day Avg. Volume0
30 Day Avg. Volume1,958
Financial Highlights & Ratios
PEG Ratio-0.89
Price to Book (P/B)3.90
Price to Sales (P/S)3.49
P/FCF Ratio49.97
Enterprise Value/Market Cap4.37
Enterprise Value/Revenue6.01
Enterprise Value/Gross Profit24.08
Enterprise Value/Ebitda38.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.99
Revenue Forecast (FY)$26.21B
Fresenius SE & Co News
FSNUY FAQ
What was Fresenius Se’s price range in the past 12 months?
Fresenius Se lowest stock price was $8.60 and its highest was $14.74 in the past 12 months.
What is Fresenius Se’s market cap?
Fresenius Se’s market cap is $32.01B.
When is Fresenius Se’s upcoming earnings report date?
Fresenius Se’s upcoming earnings report date is Feb 25, 2026 which is in 59 days.
How were Fresenius Se’s earnings last quarter?
Fresenius Se released its earnings results on Nov 05, 2025. The company reported $0.178 earnings per share for the quarter, missing the consensus estimate of $0.208 by -$0.03.
Is Fresenius Se overvalued?
According to Wall Street analysts Fresenius Se’s price is currently Overvalued.
Does Fresenius Se pay dividends?
Fresenius Se pays a Annually dividend of $0.283 which represents an annual dividend yield of 1.97%. See more information on Fresenius Se dividends here
What is Fresenius Se’s EPS estimate?
Fresenius Se’s EPS estimate is 0.26.
How many shares outstanding does Fresenius Se have?
Fresenius Se has 2,252,949,200 shares outstanding.
What happened to Fresenius Se’s price movement after its last earnings report?
Fresenius Se reported an EPS of $0.178 in its last earnings report, missing expectations of $0.208. Following the earnings report the stock price went down -1.076%.
Which hedge fund is a major shareholder of Fresenius Se?
Currently, no hedge funds are holding shares in FSNUY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Fresenius SE & Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.93%
12-Months-Change
Fundamentals
Return on Equity
7.22%
Trailing 12-Months
Asset Growth
5.51%
Trailing 12-Months
Company Description
Fresenius Se
Fresenius SE & Co. KGaA is a global healthcare group based in Germany, operating in the sectors of dialysis, hospital management, and pharmaceuticals. The company is primarily known for its medical devices and services related to renal care, particularly through its Fresenius Medical Care division, which is the world's largest provider of dialysis products and services. Additionally, Fresenius operates in the pharmaceutical sector via Fresenius Kabi, focusing on injectable drugs and clinical nutrition, and in hospital management through Fresenius Helios, which manages a network of hospitals in Germany.
FSNUY Company Deck
FSNUY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Fresenius demonstrated strong performance across its core businesses, with significant EPS growth and an EBIT guidance upgrade. Despite facing macroeconomic and geopolitical challenges, the company maintained strong operational execution, particularly in its Kabi and biopharma segments. The DRG inflator in Germany and U.S. tariffs present potential headwinds, but the overall momentum remains positive.View all FSNUY earnings summariesTechnical Analysis
DaVita
―
Fresenius Medical Care
―
HCA Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---